Aplastic anemia, membranous nephropathy and mercury

1. Uppin MS, Prayaga AK, Murty KV. Utility of renal allograft biopsy: An audit of 80 allograft biopsies. Indian J Nephrol 2013;23:155‐6. 2. Kazi J, Mubarak M. Biopsy findings in renal allograft dysfunction in a live related renal transplant program. J Transplant Technol Res 2012;2:108. 3. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, et al. Antibody‐mediated rejection criteria‐An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003;3:708‐14. 4. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, et al. Banff ‘05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007;7:518‐26. 5. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002;13:779‐87. 6. Sakhuja V, Kohli HS. End‐stage renal disease in India and Pakistan: Incidence, causes, and management. Ethn Dis 2006;16 (2 Suppl 2):S2‐20‐3.